Sign inGet started

SARGEN GREGORY

Insider CIK 1227835 · TARA Director · PPHM Director · CBM Executive Vice President & CFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TARA Protara Therapeutics, Inc. A Award deriv2026-06-152026-06-1631,000— $031,000SEC↗
TARA Protara Therapeutics, Inc. A Award deriv2025-06-122025-06-1324,000— $024,000SEC↗
CDMO Avid Bioservices, Inc. D To issuer deriv2025-02-052025-02-0775,000— $049,305SEC↗
CDMO Avid Bioservices, Inc. D To issuer deriv2025-02-052025-02-078,147— $00SEC↗
CDMO Avid Bioservices, Inc. D To issuer deriv2025-02-052025-02-0710,030— $00SEC↗
CDMO Avid Bioservices, Inc. D To issuer deriv2025-02-052025-02-0719,675— $010,030SEC↗
CDMO Avid Bioservices, Inc. D To issuer deriv2025-02-052025-02-0719,600— $029,705SEC↗
CDMO Avid Bioservices, Inc. D To issuer2025-02-052025-02-0736,368— $00SEC↗
CDMO Avid Bioservices, Inc. M Exercise deriv2024-12-142024-12-1726,756— $00SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2024-12-142024-12-178,147— $08,147SEC↗
CDMO Avid Bioservices, Inc. M Exercise2024-12-142024-12-1726,756— $036,368SEC↗
TARA Protara Therapeutics, Inc. A Award deriv2024-06-072024-06-1010,000— $010,000SEC↗
CDMO Avid Bioservices, Inc. M Exercise deriv2023-12-142023-12-189,612— $00SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2023-12-142023-12-1826,756— $026,756SEC↗
CDMO Avid Bioservices, Inc. M Exercise2023-12-142023-12-189,612— $09,612SEC↗
TARA Protara Therapeutics, Inc. A Award deriv2023-06-072023-06-0810,000— $010,000SEC↗
CDMO Avid Bioservices, Inc. S Sale2023-04-112023-04-127,011$20.24 $141.9K0SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2022-12-142022-12-169,612— $09,612SEC↗
CDMO Avid Bioservices, Inc. M Exercise deriv2022-12-142022-12-164,632— $00SEC↗
CDMO Avid Bioservices, Inc. M Exercise2022-12-142022-12-164,632— $07,011SEC↗
TARA Protara Therapeutics, Inc. A Award deriv2022-06-082022-06-0910,000— $010,000SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2021-12-142021-12-164,632— $04,632SEC↗
CDMO Avid Bioservices, Inc. M Exercise deriv2021-12-142021-12-162,379— $00SEC↗
CDMO Avid Bioservices, Inc. M Exercise2021-12-142021-12-162,379— $02,379SEC↗
TARA Protara Therapeutics, Inc. A Award deriv2021-06-092021-06-1010,000— $010,000SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2020-12-142020-12-162,379— $02,379SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2020-12-142020-12-1610,030— $0124,305SEC↗
TARA Protara Therapeutics, Inc. A Award deriv2020-06-092020-06-119,000— $09,000SEC↗
TARA ArTara Therapeutics, Inc. A Award2020-01-102020-01-1331,000— $031,000SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2020-01-092020-01-1319,675— $0114,275SEC↗
CBM CAMBREX CORP M Exercise deriv2019-12-042019-12-057,500— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2019-12-042019-12-0515,000— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2019-12-042019-12-0522,500— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2019-12-042019-12-0525,000— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2019-12-042019-12-0520,000— $00SEC↗
CBM CAMBREX CORP M Exercise2019-12-042019-12-0525,000$45.64 $1.14M102,425SEC↗
CBM CAMBREX CORP M Exercise2019-12-042019-12-0520,000$53.61 $1.07M122,425SEC↗
CBM CAMBREX CORP M Exercise2019-12-042019-12-0515,000$41.36 $620.4K54,925SEC↗
CBM CAMBREX CORP M Exercise2019-12-042019-12-0522,500$40.65 $914.6K77,425SEC↗
CBM CAMBREX CORP M Exercise2019-12-042019-12-057,500$17.81 $133.6K39,925SEC↗
CBM CAMBREX CORP S Sale2019-12-042019-12-05165,925$60.00 $9.96M0SEC↗
CBM CAMBREX CORP A Award2019-12-042019-12-0543,500— $0165,925SEC↗
CBM CAMBREX CORP S Sale2019-02-152019-02-195,802$37.45 $217.3K32,425SEC↗
CBM CAMBREX CORP A Award2019-02-152019-02-1912,000— $038,227SEC↗
CBM CAMBREX CORP A Award2019-01-312019-02-046,227— $026,227SEC↗
CDMO Avid Bioservices, Inc. A Award deriv2018-12-142018-12-1819,600— $094,600SEC↗
CBM CAMBREX CORP A Award deriv2018-10-242018-10-2620,000— $020,000SEC↗
CBM CAMBREX CORP M Exercise deriv2018-05-082018-05-0915,000— $015,000SEC↗
CBM CAMBREX CORP M Exercise deriv2018-05-082018-05-097,500— $07,500SEC↗
CBM CAMBREX CORP M Exercise deriv2018-05-082018-05-097,500— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2018-05-082018-05-097,500— $022,500SEC↗
CBM CAMBREX CORP A Award2018-05-082018-05-0915,000$41.36 $620.4K56,998SEC↗
CBM CAMBREX CORP S Sale2018-05-082018-05-0933,933$49.63 $1.68M20,000SEC↗
CBM CAMBREX CORP S Sale2018-05-082018-05-0910,565$49.05 $518.2K53,933SEC↗
CBM CAMBREX CORP A Award2018-05-082018-05-097,500$40.65 $304.9K64,498SEC↗
CBM CAMBREX CORP A Award2018-05-082018-05-097,500$17.81 $133.6K41,998SEC↗
CBM CAMBREX CORP A Award2018-05-082018-05-097,500$16.91 $126.8K34,498SEC↗
CBM CAMBREX CORP A Award2018-05-072018-05-0930,000— $050,000SEC↗
CBM CAMBREX CORP S Sale2018-05-072018-05-0923,002$49.46 $1.14M26,998SEC↗
PPHM PEREGRINE PHARMACEUTICALS A Award deriv2017-11-272017-11-2975,000— $075,000SEC↗
CBM CAMBREX CORP A Award deriv2017-10-302017-11-0125,000— $025,000SEC↗
CBM CAMBREX CORP S Sale2017-02-072017-02-0830,000$54.88 $1.65M20,000SEC↗
CBM CAMBREX CORP A Award2017-02-072017-02-0830,000— $050,000SEC↗
CBM CAMBREX CORP M Exercise deriv2016-11-112016-11-147,500— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2016-11-112016-11-147,500— $015,000SEC↗
CBM CAMBREX CORP M Exercise deriv2016-11-112016-11-147,500— $07,500SEC↗
CBM CAMBREX CORP M Exercise2016-11-112016-11-147,500$17.81 $133.6K42,500SEC↗
CBM CAMBREX CORP S Sale2016-11-112016-11-1422,500$52.02 $1.17M20,000SEC↗
CBM CAMBREX CORP M Exercise2016-11-112016-11-147,500$16.91 $126.8K35,000SEC↗
CBM CAMBREX CORP M Exercise2016-11-112016-11-147,500$12.46 $93.5K27,500SEC↗
CBM CAMBREX CORP A Award deriv2016-10-262016-10-2830,000— $030,000SEC↗
CBM CAMBREX CORP S Sale2016-03-092016-03-1126,697$41.37 $1.10M20,000SEC↗
CBM CAMBREX CORP A Award2016-02-112016-02-1227,000— $060,319SEC↗
CBM CAMBREX CORP S Sale2016-02-112016-02-1212,400$36.11 $447.8K47,919SEC↗
CBM CAMBREX CORP S Sale2016-02-112016-02-121,222$36.63 $44.8K46,697SEC↗
CBM CAMBREX CORP M Exercise deriv2015-11-132015-11-166,250— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2015-11-132015-11-167,500— $07,500SEC↗
CBM CAMBREX CORP M Exercise deriv2015-11-132015-11-167,500— $015,000SEC↗
CBM CAMBREX CORP M Exercise deriv2015-11-132015-11-167,500— $022,500SEC↗
CBM CAMBREX CORP M Exercise2015-11-132015-11-167,500$12.46 $93.5K47,069SEC↗
CBM CAMBREX CORP M Exercise2015-11-132015-11-166,250$5.72 $35.8K39,569SEC↗
CBM CAMBREX CORP M Exercise2015-11-132015-11-167,500$16.91 $126.8K54,569SEC↗
CBM CAMBREX CORP S Sale2015-11-132015-11-1628,750$49.14 $1.41M33,319SEC↗
CBM CAMBREX CORP M Exercise2015-11-132015-11-167,500$17.81 $133.6K62,069SEC↗
CBM CAMBREX CORP A Award deriv2015-10-212015-10-2730,000— $030,000SEC↗
CBM CAMBREX CORP M Exercise2015-08-042015-08-0518,750$5.72 $107.3K74,569SEC↗
CBM CAMBREX CORP M Exercise deriv2015-08-032015-08-0518,750— $06,250SEC↗
CBM CAMBREX CORP M Exercise deriv2015-08-032015-08-0515,000— $015,000SEC↗
CBM CAMBREX CORP M Exercise deriv2015-08-032015-08-057,500— $022,500SEC↗
CBM CAMBREX CORP M Exercise2015-08-032015-08-0515,000$12.46 $186.9K48,319SEC↗
CBM CAMBREX CORP M Exercise2015-08-032015-08-057,500$16.91 $126.8K55,819SEC↗
CBM CAMBREX CORP S Sale2015-08-032015-08-0541,250$49.60 $2.05M33,319SEC↗
CBM CAMBREX CORP M Exercise deriv2015-05-112015-05-1225,000— $00SEC↗
CBM CAMBREX CORP S Sale2015-05-112015-05-1225,000$38.44 $961.0K33,319SEC↗
CBM CAMBREX CORP M Exercise2015-05-112015-05-1225,000$4.38 $109.5K58,319SEC↗
CBM CAMBREX CORP M Exercise deriv2015-02-122015-02-1325,000— $025,000SEC↗
CBM CAMBREX CORP S Sale2015-02-122015-02-1325,000$32.64 $816.0K33,319SEC↗
CBM CAMBREX CORP M Exercise2015-02-122015-02-1325,000$4.38 $109.5K58,319SEC↗
CBM CAMBREX CORP M Exercise deriv2014-10-222014-10-2330,000— $030,000SEC↗
CBM CAMBREX CORP M Exercise deriv2014-08-052014-08-0750,000— $00SEC↗
CBM CAMBREX CORP S Sale2014-08-052014-08-0750,000$22.34 $1.12M33,319SEC↗
CBM CAMBREX CORP M Exercise2014-08-052014-08-0750,000$5.51 $275.5K83,319SEC↗
CBM CAMBREX CORP M Exercise deriv2014-02-182014-02-208,500— $00SEC↗
CBM CAMBREX CORP M Exercise deriv2014-02-182014-02-2030,000— $050,000SEC↗
CBM CAMBREX CORP S Sale2014-02-182014-02-2038,500$21.66 $833.9K33,319SEC↗
CBM CAMBREX CORP M Exercise2014-02-182014-02-208,500$13.75 $116.9K41,819SEC↗
CBM CAMBREX CORP M Exercise2014-02-182014-02-2030,000$5.51 $165.3K71,819SEC↗
CBM CAMBREX CORP M Exercise deriv2013-11-112013-11-1220,000— $080,000SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-121,063$18.96 $20.2K49,141SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-121,200$18.97 $22.8K50,204SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12200$18.98 $3.8K51,404SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12411$18.99 $7.8K51,604SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12604$19.01 $11.5K52,015SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12100$19.02 $1.9K52,619SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12100$19.03 $1.9K52,719SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12400$19.05 $7.6K52,819SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-12100$19.07 $1.9K53,219SEC↗
CBM CAMBREX CORP M Exercise2013-11-112013-11-1220,000$5.51 $110.2K53,319SEC↗
CBM CAMBREX CORP S Sale2013-11-112013-11-1215,822$18.90 $299.0K33,319SEC↗
CBM CAMBREX CORP A Award deriv2013-10-282013-10-3030,000— $030,000SEC↗
CBM CAMBREX CORP M Exercise deriv2013-05-072013-05-082,500— $00SEC↗
CBM CAMBREX CORP M Exercise2013-05-072013-05-082,500$7.39 $18.5K35,819SEC↗
CBM CAMBREX CORP A Award deriv2012-10-242012-10-2630,000— $030,000SEC↗
CBM CAMBREX CORP S Sale2012-05-072013-05-082,500$12.42 $31.1K33,319SEC↗